BRCA
FDA authorises first direct-to-consumer test for BRCA mutations, with caveats
March 6, 2018Research and Development, Sales and Marketing 23andME, BRCA, Cancer, FDA, breast cancer, ovarian cancer, pharma
The FDA has given its authorisation to the first ever direct-to-consumer (DTC) test to identify three BRCA gene mutations which …
Research calls for BRCA testing in all women
January 18, 2018Medical Communications, Research and Development BRCA, biotech, drugs, pharma, pharmaceutical
For women, possessing a mutated BRCA1 or BRCA2 gene significantly increases the chances of developing breast or ovarian cancer; at …
Risk estimate produced from long-term BRCA gene study
June 22, 2017Research and Development BRCA, Cancer Research UK, University of Cambridge
A new study funded by Cancer Research UK and carried out by the University of Cambridge has identified the ages …
AstraZeneca ovarian cancer drug approved in Europe
December 18, 2014Sales and Marketing AstraZeneca, BRCA, Cambridge, Cancer, FDA, lynparza, olaparib, ovarian
The European Commission has approved AstraZeneca’s Lynparza for the treatment of advanced BRCA-mutated ovarian cancer. Lynparza (olaparib) has been approved …
Quest starts selling BRCA tests
October 17, 2013Sales and Marketing BRCA, Myriad, Quest, jolie
Quest Diagnostics has begun selling a genetic test to uncover the risk of hereditary breast cancer, after the US Supreme …
Latest content
